Xcout Intel
Monograph Capital competitors & alternatives
The 4 closest competitors and alternatives to Monograph Capital among biotech companies — ranked by similarity to what Monograph Capital actually does, not by market-cap band.
Subscribe to see Monograph Capital’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Monograph Capital
Monograph Capital is a life-sciences investment firm that provides venture capital to companies developing innovative therapeutics and related healthcare technologies. It works with entrepreneurs and management teams building businesses in the biotechnology and healthcare sectors.
Monograph Capital at a glance
Monograph Capital is a biotech company headquartered in United Kingdom. Xcout tracks 10 named people at Monograph Capital, including Mike LaGatta (Partner and COO). Xcout recorded 5 job postings from Monograph Capital in the last 90 days.
Monograph Capital leadership
- Mike LaGattaPartner and COO
- Daniel SchwarzChief Financial Officer
- Fred CohenPartner and Chairman
- Charles ConnPartner
- Tim FunnellPartner
- Jennifer ShahHead of Capital Formation
4 more named people on record for Monograph Capital, with roles, board committees and tenure — see the full roster →
Hiring at Monograph Capital
Xcout recorded 5 job postings from Monograph Capital in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Monograph Capital's hiring signals →
Top 4 Monograph Capital competitors
Ranked by semantic similarity — how close each company is to Monograph Capital by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Asset Management
Forbion is a European venture capital firm focused on life sciences, including biotechnology and medical technology. It manages investment funds and provides capital to innovative healthcare companies, primarily serving entrepreneurs and investors in the European life sciences sector.
Asset Management
Casdin Capital is an investment firm focused on the life sciences and healthcare sectors, including biotechnology, medical technology, and related companies. It serves institutional and other sophisticated investors through investment strategies targeting growth and innovation in healthcare.
Asset Management
Tachyon Ventures is a life-sciences venture capital firm that provides early-stage funding and smart capital to entrepreneurs and researchers in medicine, biotech, and bioengineering. The firm focuses on pre-Seed, Seed, and Series A investments in IP-backed, transformational scientific platforms.
Asset Management
RTW Venture Fund Limited primarily focuses on sourcing groundbreaking innovations poised for substantial growth within the biotechnology, pharmaceutical, and medical technology fields. The fund allocates capital to enterprises that are engineering advanced therapies and cutting-edge technologies, ultimately aiming to profoundly enhance patient quality of life.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Monograph Capital and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Monograph Capitaland every competitor above — in one live dashboard.
Subscribe to Xcout Intel →